Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin.
about
The Anti-Factor Xa Range For Low Molecular Weight Heparin ThromboprophylaxisWeight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patientsThe Daniel K. Inouye College of Pharmacy Scripts: Obesity: The Drug Dose Debate.Appropriate enoxaparin dose for venous thromboembolism prophylaxis in patients with extreme obesity.Measurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays.Prevention of venous thromboembolism in obesity.Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospective, randomised pilot study evaluating two doses of parnaparin (BAFLUX Study).Anticoagulating obese patients in the modern era.Pharmacologic prevention of venous thromboembolism in obese patients.Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations.Fixed-dose enoxaparin after bariatric surgery: the influence of body weight on peak anti-Xa levels.Pharmacokinetics of rivaroxaban after bariatric surgery: a case report.Use of Enoxaparin in Obese Adolescents During Bariatric Surgery--a Pilot Study.Deep vein thrombosis prophylaxis: Are we overdoing? An Asian survey on trends in bariatric surgery with a systematic review of literature.Identifying the Bariatric Patient at Risk for Pulmonary Embolism: Prospective Clinical Trial Using Duplex Sonography and Blood Screening.Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients.Adjusted-Dose Enoxaparin for VTE Prevention in the Morbidly Obese.Low-Molecular-Weight Heparin Prophylaxis Dosing: Is Weight an Issue?
P2860
Q26770822-3A137FE6-AD69-4B1A-9570-DADD7583AD16Q33383622-25D8C2BA-CE70-469F-B3E7-8607DF16EF86Q33763123-3BD10628-D03F-4ED7-8C09-C98B4A19104CQ34612869-75B6B00C-1DA8-4B25-AED0-6EC1D3C896D2Q35154142-B8BEFB50-DD51-4BF2-BFCD-3777DFEAD68CQ35633708-C34B0051-1B5E-42C7-A43A-F0B3DB8FC49FQ37453595-32FE2D3C-28A2-42A2-A623-EE1D34F1F4D9Q37919151-15081594-7722-4BE2-BA4E-BA019FFC438EQ38062477-B54AE77E-46A8-4001-A926-631E87D6FCD5Q38485825-801F73DC-F4B7-493F-8067-EDB6470E9723Q43426032-D641B996-5105-497C-A7E3-0CAD39A3C08AQ45727029-435AAB75-4093-425A-BD48-AA7DB545F3D5Q46618514-E801326A-003E-44B7-91CD-1F77295E0EC5Q47332333-C459F6F8-933E-4154-AD0A-545CF566212AQ47985617-67F05D1E-3848-4AE5-805D-59E0E94A9FD4Q50999671-C17879B8-95AF-47D5-B75D-362BB7142A13Q53101380-1BC720BE-582F-4410-8F0D-3602D76A272AQ55235456-681674D7-F9CC-4A39-9DEB-964F65E68D11Q55261242-DE96CAF6-3CB7-43FE-8025-72D94882B107
P2860
Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin.
@en
Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin.
@nl
type
label
Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin.
@en
Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin.
@nl
prefLabel
Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin.
@en
Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin.
@nl
P2093
P1433
P1476
Anti-Xa levels in bariatric surgery patients receiving prophylactic enoxaparin.
@en
P2093
Atul K Madan
Brea O Rowan
David A Kuhl
David S Tichansky
Marilyn D Lee
P2888
P304
P356
10.1007/S11695-007-9381-Y
P577
2007-12-29T00:00:00Z